Start Licensing, Inc. Challenges Korean Company's Provision Of Dog Cloning Services
"Start will protect its patent rights," said Jonathan Thatcher, President of Start Licensing. "We will take all necessary actions and pursue every available legal remedy to do so."
About Start Licensing
Start is a joint venture of Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. Start manages and licenses a broad portfolio of intellectual property rights related to animal reproductive technologies, including foundational nuclear transfer cloning technology developed at the Roslin Institute for the cloning of Dolly the sheep. Start's licensees are on the cutting edge of research and product development in food production, medical applications and many other fields.
Geron Corporation
Start pentru eliberarea licentelor, Inc provocãri coreean companiei furnizarea de servicii de clonare de câine - Start Licensing, Inc. Challenges Korean Company's Provision Of Dog Cloning Services - articole medicale engleza - startsanatate